Clinical Trial Update: Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety and pharmacokinetics of the novel drug YN001 in combination with Rosuvastatin in healthy Chinese subjects. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cerebrovascular Disease

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• YN001

Snippet

Sponsor: Beijing Inno Medicine Co., Ltd. | Conditions: Atherosclerotic Cardiovascular Diseases, Cerebrovascular Diseases | Phase 1 | Status: NOT_YET_RECRUITING